Compare LIQT & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIQT | COSM |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 16.1M |
| IPO Year | N/A | 2013 |
| Metric | LIQT | COSM |
|---|---|---|
| Price | $1.88 | $0.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.20 | N/A |
| AVG Volume (30 Days) | 16.3K | ★ 611.1K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,788,295.00 | ★ $59,792,819.00 |
| Revenue This Year | $34.09 | $28.14 |
| Revenue Next Year | $18.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.97 | 6.69 |
| 52 Week Low | $1.34 | $0.28 |
| 52 Week High | $3.35 | $1.32 |
| Indicator | LIQT | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 40.45 | 23.06 |
| Support Level | $1.81 | $0.44 |
| Resistance Level | $2.14 | $0.66 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 2.47 | 6.86 |
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.